Author Credentials

Farley B. Neasman III, Melissa D. Lester, DO, Nepal C. Chowdhury, MD


STEMI, retroperitoneal hemorrrhage, abdominal aortic aneurysm, anticoagulation


Cardiology | Surgery | Trauma


When patients present with life threatening conditions, a rapid cost-benefit analysis prioritizes care and commits treatment to a certain course that, in the case of ST Elevation Myocardial Infarction (STEMI) treated with drug-eluting stents (DES), could be fatal if there is any deviation. Antiplatelet therapy is vital and secondary concerns (i.e. bleeding diatheses) may accept suboptimal outcomes – in rare cases, another life-threatening condition may be unmasked, the treatment for which runs directly counter to the first. We present a case of STEMI with high clot burden treated with multiple DES, complicated by retroperitoneal hemorrhage due to a ruptured abdominal aortic aneurysm.